The p53-reactivating small molecule RITA induces senescence in head and neck cancer cells

Hui-Ching Chuang1, Liang Peng Yang2, Alison L Fitzgerald3

  • 1Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America; Department of Otolaryngology, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung, Taiwan.

Plos One
|August 15, 2014
PubMed

Insights

RITA treatment accelerates senescence in head and neck cancer (HNSCC) cells, a process partly independent of TP53 mutations. This finding suggests novel therapeutic strategies for HNSCC by combining RITA with DNA damage response activators or SIRT1 inhibitors.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Research

Background:

  • TP53 gene mutations are prevalent in head and neck squamous cell carcinoma (HNSCC) and linked to therapeutic resistance.
  • RITA (reactivation of p53 and induction of tumor cell apoptosis) is a small molecule designed to restore p53 function and induce cancer cell death.

Purpose of the Study:

  • To investigate the effects of RITA on HNSCC cells.
  • To elucidate the mechanism of RITA's action, particularly concerning senescence induction.

Main Methods:

  • Treatment of HNSCC cell lines with RITA.
  • Analysis of p53 status, senescence markers, DNA damage response activation, and SIRT1 activity.
  • Combination studies with ionizing radiation and SIRT1 inhibition.

Main Results:

  • RITA induced significant effects in HNSCC cells, primarily accelerated senescence.
  • RITA-induced senescence occurred across various p53 backgrounds, including p53-null cells, indicating partial p53 independence.
  • Senescence was partially mediated by DNA damage response activation and SIRT1 inhibition, with synergistic effects observed when combined with RITA.

Conclusions:

  • RITA exhibits a novel mechanism of action in HNSCC, inducing p53-independent senescence.
  • The findings suggest potential therapeutic benefits of combining RITA with agents targeting the DNA damage response or SIRT1 for HNSCC treatment.

Related Concept Videos

DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
9.9K
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
3.0K
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
38.1K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.0K
Replicative Cell Senescence02:15

Replicative Cell Senescence

Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds...
4.2K
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.6K